Skip to main content

Rh immunoglobulin (Rhogam) for Rh negative pregnant women at risk of fetal blood exposure.

CBE ID
0652
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percent of Rh negative pregnant women at risk of fetal blood exposure who receive Rhogam the ED.

        • 1.14 Numerator

          Number of appropriate patients who receive Rhogam in the ED.

        • 1.15 Denominator

          All women, confirmed pregnant, who are at significant risk of fetal blood exposure, including:
          1. those diagnosed with an ectopic pregnancy
          2. those in the second or third trimester:
          a: with a threatened abortion (threatened, partial, complete, or spontaneous)
          b. those who report or are found to have significant vaginal bleeding (not just spotting)
          c. those who have sustained blunt abdominal trauma
          3. those who undergo an invasive obstetric procedure in the ED (genetic amniocentesis; chorion villus sampling; fetal blood sampling, D&C).

        • Exclusions

          1. Patient refusal
          2. Patients who have received appropriate Rh immunoglobulin previously
          3. OB/GYN consultation documenting Rh immunoglobulin not recommended

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed National Voluntary Consensus Standards for Ambulatory Care: Additional Outpatient Measures 2010
          Initial Endorsement
          Last Updated
          Removal Date